JPMorgan International Research Enhanced Equity ETF is an active ETF seeking to outperform the MSCI EAFE Index with similar risk. It closely tracks the benchmark in sector/country allocations, fundamentals, volatility, and historical returns. Despite active management, JIRE's performance edge is minimal, but its cost advantage over EFA supports its use as a core EAFE equity holding.
On September 30, 2024, FMR LLC (Trades, Portfolio), a prominent investment firm, executed a significant transaction by acquiring 3,127,577 shares of JPMorgan International Research Enhanced Equity ETF (JIRE, Financial). This addition has increased FMR LLC (Trades, Portfolio)'s total holdings in JIRE to 12,172,033 shares, reflecting a trade impact of 0.01% on their portfolio.
JPMorgan International Research Enhanced Equity ETF launched as an ETF in June 2022 after operating as a mutual fund. JIRE invests in developed markets, with a focus on financials, industrials, healthcare, and consumer discretionary sectors. The fund has shown resilience against the S&P 500, making it a potential hedge against potential U.S. economic uncertainties.